Ident. | Authors (with country if any) | Title |
---|
000027 (2020) |
Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann | [SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy]. |
000040 (2020) |
X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine] | [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. |
000049 (2020) |
B. El Boussadani [Maroc] ; C. Benajiba [Maroc] ; A. Aajal [Maroc] ; A. Ait Brik [Maroc] ; O. Ammour [Maroc] ; J. El Hangouch [Maroc] ; O. Oussama [Maroc] ; B. Oussama [Maroc] ; N. Tahiri [Maroc] ; Z. Raissuni [Maroc] | [COVID-19 pandemia: Impact on the cariovascular system. Data of 1st April 2020]. |
000095 (2020) |
Mingxiang Ye [République populaire de Chine] ; Dian Fu [République populaire de Chine] ; Yi Ren [République populaire de Chine] ; Faxiang Wang [République populaire de Chine] ; Dong Wang [République populaire de Chine] ; Fang Zhang [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Tangfeng Lv [République populaire de Chine] | Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. |
000101 (2020) |
Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
000125 (2020) |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
000167 (2020) |
Leon Caly [Australie] ; Julian D. Druce [Australie] ; Mike G. Catton [Australie] ; David A. Jans [Australie] ; Kylie M. Wagstaff [Australie] | The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. |
000186 (2020) |
Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis] | Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies. |
000241 (2020) |
Indwiani Astuti | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response |
000286 (2020) |
Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola Roviello | SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. |
000300 (2020) |
Ashley Barlow [États-Unis] ; Kaitlin M. Landolf [États-Unis] ; Brooke Barlow [États-Unis] ; Siu Yan Amy Yeung [États-Unis] ; Jason J. Heavner [États-Unis] ; Cassidy W. Claassen [Zambie] ; Mojdeh S. Heavner [États-Unis] | Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. |
000331 (2020) |
Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde] | Recent discovery and development of inhibitors targeting coronaviruses |
000385 (2020) |
Giuseppe Rombolà [Italie] ; Marco Hedemperger [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie] | Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy |
000387 (2020) |
Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran] | Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. |
000454 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
000474 (2020) |
Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
000491 (2020) |
Pietro H. Guzzi [Italie] ; Daniele Mercatelli [Italie] ; Carmine Ceraolo [Italie] ; Federico M. Giorgi [Italie] | Master Regulator Analysis of the SARS-CoV-2/Human Interactome. |
000546 (2020) |
Gionata Fiorino [Italie] ; Mariangela Allocca [Italie] ; Federica Furfaro [Italie] ; Daniela Gilardi [Italie] ; Alessandra Zilli [Italie] ; Simona Radice [Italie] ; Antonino Spinelli [Italie] ; Silvio Danese [Italie] | Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience. |
000586 (2020) |
P. Conti [Italie] ; C E Gallenga [Italie] ; G. Tetè [Italie] ; Al Caraffa [Italie] ; G. Ronconi [Italie] ; A. Younes [Italie] ; E. Toniato [Italie] ; R. Ross [États-Unis] ; S K Kritas [Grèce] | How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. |
000761 (2020) |
Stephan Ludwig [Allemagne] ; Alexander Zarbock [Allemagne] | Coronaviruses and SARS-CoV-2: A Brief Overview. |
000879 (2020) |
Bingwen Liu [République populaire de Chine] ; Min Li [République populaire de Chine] ; Zhiguang Zhou [République populaire de Chine] ; Xuan Guan [États-Unis] ; Yufei Xiang [République populaire de Chine] | Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? |
000896 (2020) |
Peipei Song [Japon] ; Takashi Karako [Japon] | COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern. |
000900 (2020) |
Thomas P. Lodise [États-Unis] ; Michael J. Rybak [États-Unis] | COVID-19: Important Therapy Considerations and Approaches in this Hour of Need. |
000921 (2020) |
Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie] | COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
000931 (2020) |
Deepak Atri [États-Unis] ; Hasan K. Siddiqi [États-Unis] ; Joshua Lang [États-Unis] ; Victor Nauffal [États-Unis] ; David A. Morrow [États-Unis] ; Erin A. Bohula [États-Unis] | COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. |
000986 (2020) |
Mahmoud Yousefifard [Iran] ; Alireza Zali [Iran] ; Kosar Mohamed Ali [Iraq] ; Arian Madani Neishaboori [Iran] ; Afshin Zarghi [Iran] ; Mostafa Hosseini [Iran] ; Saeed Safari [Iran] | Antiviral therapy in management of COVID-19: a systematic review on current evidence |
000997 (2020) |
Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine] | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods |
000B03 (????) |
Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Al-Ahmed [Arabie saoudite] ; Shafiul Haque [Arabie saoudite] ; Ranjit Sah [Népal] ; Ruchi Tiwari [Inde] ; Yashpal Singh Malik [Inde] ; Kuldeep Dhama [Inde] ; M Iqbal Yatoo [Inde] ; D Katterine Bonilla-Aldana ; Alfonso J. Rodriguez-Morales [Colombie] | SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview |